Literature DB >> 20149358

Serum inhibin-b in fertile men is strongly correlated with low but not high sperm counts: a coordinated study of 1,797 European and US men.

Niels Jørgensen1, Fan Liu, Anna-Maria Andersson, Matti Vierula, D Stewart Irvine, Jacques Auger, Charlene K Brazil, Erma Z Drobnis, Tina K Jensen, Pierre Jouannet, James W Overstreet, J Bruce Redmon, Amy Sparks, Jorma Toppari, Christina Wang, Niels E Skakkebæk, Shanna H Swan.   

Abstract

OBJECTIVE: To describe associations between serum inhibin-b and sperm counts, adjusted for effect of time of blood sampling, in larger cohorts than have been previously reported.
DESIGN: Cross-sectional studies of spermatogenesis markers.
SETTING: Four European and four US centers. PATIENT(S): Fertile men (1,797) were included and examined from October 1996-February 2005. INTERVENTION(S): The study was observational and therefore without any intervention. MAIN OUTCOME MEASURE(S): Associations between inhibin-b and semen variables controlled for time of blood sampling and other covariates. RESULT(S): Inhibin-b decreased about 2.00% per hour from 8 am-12 pm and then about 3.25% per hour from 12 pm-4 pm. There was a strong positive association between inhibin-b levels less than 150 pg/mL and both sperm concentration and total sperm count (slopes of the regression lines were β=0.011 and β=0.013 for natural logarithm-transformed sperm concentration and total sperm count, respectively). For inhibin-b levels of 150-300 pg/mL the associations were not as steep (β=0.002), but still significant. For inhibin-b levels more than 300 pg/mL there was little association to the sperm counts. Neither sperm motility nor morphology was significantly related to inhibin-b level in any group. CONCLUSION(S): Serum inhibin-b levels decrease nonlinearly during the daytime, and are positively correlated with sperm counts, but the predictive power is best when inhibin-b is low.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149358      PMCID: PMC5034728          DOI: 10.1016/j.fertnstert.2009.12.051

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

1.  Sperm morphology, motility, and concentration in fertile and infertile men.

Authors:  D S Guzick; J W Overstreet; P Factor-Litvak; C K Brazil; S T Nakajima; C Coutifaris; S A Carson; P Cisneros; M P Steinkampf; J A Hill; D Xu; D L Vogel
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities.

Authors:  R Slama; F Eustache; B Ducot; T K Jensen; N Jørgensen; A Horte; S Irvine; J Suominen; A G Andersen; J Auger; M Vierula; J Toppari; A N Andersen; N Keiding; N E Skakkebaek; A Spira; P Jouannet
Journal:  Hum Reprod       Date:  2002-02       Impact factor: 6.918

3.  Diurnal rhythm in serum levels of inhibin B in normal men: relation to testicular steroids and gonadotropins.

Authors:  E Carlsen; C Olsson; J H Petersen; A M Andersson; N E Skakkebaek
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

4.  The evaluation of morphological characteristics of human spermatozoa according to stricter criteria.

Authors:  R Menkveld; F S Stander; T J Kotze; T F Kruger; J A van Zyl
Journal:  Hum Reprod       Date:  1990-07       Impact factor: 6.918

5.  Serum inhibin B as a marker of spermatogenesis.

Authors:  F H Pierik; J T Vreeburg; T Stijnen; F H De Jong; R F Weber
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

6.  Regional differences in semen quality in Europe.

Authors:  N Jørgensen; A G Andersen; F Eustache; D S Irvine; J Suominen; J H Petersen; A N Andersen; J Auger; E H Cawood; A Horte; T K Jensen; P Jouannet; N Keiding; M Vierula; J Toppari; N E Skakkebaek
Journal:  Hum Reprod       Date:  2001-05       Impact factor: 6.918

7.  Immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach.

Authors:  N Groome; M O'Brien
Journal:  J Immunol Methods       Date:  1993-10-15       Impact factor: 2.303

8.  Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners.

Authors:  J P Bonde; E Ernst; T K Jensen; N H Hjollund; H Kolstad; T B Henriksen; T Scheike; A Giwercman; J Olsen; N E Skakkebaek
Journal:  Lancet       Date:  1998-10-10       Impact factor: 79.321

9.  Relationship between sperm characteristics and hormonal parameters in normal couples.

Authors:  Meike L Uhler; Michael J Zinaman; Charles C Brown; Eric D Clegg
Journal:  Fertil Steril       Date:  2003-06       Impact factor: 7.329

10.  Geographic differences in semen quality of fertile U.S. males.

Authors:  Shanna H Swan; Charlene Brazil; Erma Z Drobnis; Fan Liu; Robin L Kruse; Maureen Hatch; J Bruce Redmon; Christina Wang; James W Overstreet
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

View more
  19 in total

Review 1.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

2.  The impact of early and successful orchidopexy on hormonal follow-up for 208 boys with bilateral non-syndromic cryptorchidism.

Authors:  Simone Hildorf; Dina Cortes; Erik Clasen-Linde; Magdalena Fossum; Jorgen Thorup
Journal:  Pediatr Surg Int       Date:  2021-01-09       Impact factor: 1.827

Review 3.  The gonadal function in obese adolescents: review.

Authors:  Rosita A Condorelli; Aldo E Calogero; Enzo Vicari; Laura Mongioi'; Vincenzo Favilla; Giuseppe Morgia; Sebastiano Cimino; Giorgio Russo; Sandro La Vignera
Journal:  J Endocrinol Invest       Date:  2014-06-13       Impact factor: 4.256

Review 4.  Endocrinology of the aging male.

Authors:  Andre B Araujo; Gary A Wittert
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-04       Impact factor: 4.690

Review 5.  Targeting testis-specific proteins to inhibit spermatogenesis: lesson from endocrine disrupting chemicals.

Authors:  H T Wan; Dolores D Mruk; Chris K C Wong; C Yan Cheng
Journal:  Expert Opin Ther Targets       Date:  2013-04-22       Impact factor: 6.902

6.  Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?

Authors:  V A Giagulli; M D Carbone; G De Pergola; E Guastamacchia; F Resta; B Licchelli; C Sabbà; V Triggiani
Journal:  J Assist Reprod Genet       Date:  2014-04-02       Impact factor: 3.412

7.  APPROACHES TO THE 26-36-YEAR-OLD LITHUANIAN MEN'S SEXUAL FUNCTION.

Authors:  V Matulevicius; B Zilaitiene; R T Preiksa; I Banisauskaite; J Jurevičiūtė; S Abramavicius; I Matuleviciute; T Kurakovas; R Ostrauskas; R Verkauskiene; V Urbanavicius
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Apr-Jun       Impact factor: 0.877

8.  Anogenital distance is associated with semen quality but not reproductive hormones in 1106 young men from the general population.

Authors:  L Priskorn; A K Bang; L Nordkap; M Krause; J Mendiola; T K Jensen; A Juul; N E Skakkebaek; S H Swan; N Jørgensen
Journal:  Hum Reprod       Date:  2019-01-01       Impact factor: 6.918

9.  Adverse pathophysiological influence of early testosterone therapy on the testes of boys with higher grade sex chromosome aneuploidies (HGAs): a retrospective, cross-sectional study.

Authors:  M Spaziani; C Tarantino; C Pozza; A Anzuini; F Panimolle; G Papi; D Gianfrilli; A Lenzi; A F Radicioni
Journal:  J Endocrinol Invest       Date:  2020-10-24       Impact factor: 4.256

10.  Semen quality of 1559 young men from four cities in Japan: a cross-sectional population-based study.

Authors:  Teruaki Iwamoto; Shiari Nozawa; Makiko Naka Mieno; Katsunori Yamakawa; Katsuyuki Baba; Miki Yoshiike; Mikio Namiki; Eitetsu Koh; Jiro Kanaya; Akihiko Okuyama; Kiyomi Matsumiya; Akira Tsujimura; Hiroshi Kanetake; Jiro Eguchi; Niels E Skakkebaek; Matti Vierula; Jorma Toppari; Niels Jørgensen
Journal:  BMJ Open       Date:  2013-04-29       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.